Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?

International Journal of Cancer

Volumn 100, Issue 5, 2002, Pages 520-526

  Ohlmann, Carsten Henning ^a   Jung, Christine ^a   Jaques, Gabriele ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Apoptosis; Cancer therapy; Fenretinide; Lung cancer; Proliferation; Retinoids

Indexed keywords

FENRETINIDE; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CYTOSTASIS; DRUG MECHANISM; DRUG POTENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LONG TERM CARE; LUNG CANCER; LUNG SMALL CELL CANCER; NICK END LABELING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL SIZE; DOSE-RESPONSE RELATIONSHIP, DRUG; FENRETINIDE; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; LUNG NEOPLASMS; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037055534     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10525     Document Type: Article

References (42)

1. Declining cancer rates in the 1990s
2. Diet and cancer - An overview
3. Human lung cancer cell lines exhibit resistance to retinoic acid treatment
4. Adjuvant treatment of stage I lung cancer with high-dose vitamin A
5. Retinoids and chemoprevention of aerodigestive tract cancers
6. Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer
7. Fenretinide and its relation to cancer
8. Retinoids and apoptosis: Implications for cancer chemoprevention and therapy
9. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid
10. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)retinamide in human breast cancer cell lines
11. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line
12. Advances in the biology of non-small cell lung cancer
13. Establishment and identification of small cell lung cancer cell lines having classic and variant features
14. Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752)
15. Analysis of established human carcinoma cell lines for lymphoreticular-associated membrane receptors
16. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung
17. Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines
18. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in non-small cell lung cancer cell lines
19. Morphological and biochemical characterization and analysis of apoptosis
20. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
21. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines
22. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines
23. Five-year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations
24. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: Importance of bioavailability
25. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
26. The effect of tamoxifen and fenretinide on human colorectal cancer cell lines in vitro
27. All-transretinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer
28. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors
29. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: Correlation with tissue transglutaminase
30. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
31. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
32. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition
33. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity
34. Fenretinide: The death of a tumor cell
35. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells
36. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells
37. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells
38. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells
39. Safety of the synthetic retinoid fenretinide: Long-term results from a controlled clinical trial for the prevention of contralateral breast cancer
40. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid
41. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells